* Molecular Templates Inc MTEM.OQ MTEM.O is expected
to show a
rise in quarterly revenue when it reports results on May 11
(estimated).
* The Austin Texas-based company is expected to report a
59.6% increase in revenue to $5.14 million from $3.22 million a
year ago, according to the mean estimate from 6 analysts, based
on Refinitiv data.
* Refinitiv's mean analyst estimate for Molecular Templates
Inc
is for a loss of 47 cents per share. For the same quarter last
year, the company reported a loss of 51 cents per share.
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 8 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Molecular
Templates Inc is $10, above its last closing price of $1.45.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2021 0.10 -0.40 -0.18 Beat 54.7
Sep. 30 2021 -0.38 -0.38 -0.54 Missed -43
Jun. 30 2021 -0.24 -0.27 -0.28 Missed -1.8
Mar. 31 2021 0.19 0.14 -0.51 Missed -454.8
Dec. -0.47 -0.42 -0.53 Missed -26.3
31 2020
Sep. 30 2020 -0.56 -0.55 -0.47 Beat 14.8
Jun. 30 2020 -0.68 -0.48 -0.65 Missed -34.9
Mar. 31 2020 -0.35 -0.32 -0.48 Missed -50.7
This summary was machine generated May 9 at 11:03 GMT. All
figures in US dollars unless otherwise stated